Geode Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Geode Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-682,043	Closed	-$73.2M	–	4812
2023 Q1	$73.2M	Buy	682,043 +35,396	+5%	+$4.07M	0.01%	930
2022 Q4	$71.1M	Buy	646,647 +110,263	+21%	+$7.15M	0.01%	909
2022 Q3	$31.7M	Buy	536,384 +172,329	+47%	+$7.89M	﹤0.01%	1414
2022 Q2	$10.3M	Sell	364,055 -20,060	-5%	-$581K	﹤0.01%	2231
2022 Q1	$14.5M	Buy	384,115 +17,477	+5%	+$691K	﹤0.01%	2101
2021 Q4	$14.5M	Buy	366,638 +151,464	+70%	+$4.74M	﹤0.01%	2184
2021 Q3	$5.1M	Buy	215,174 +4,562	+2%	+$108K	﹤0.01%	2908
2021 Q2	$5.17M	Buy	210,612 +192,840	+1,085%	+$4.3M	﹤0.01%	2879
2021 Q1	$324K	Buy	+17,772	New	+$367K	﹤0.01%	3962

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Geode Capital Management's RXDX Position: Q2 2023 in Review

Geode Capital Management sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 682,043 shares — an estimated $73.2M sold.

Geode Capital Management first reported a position in RXDX in Q1 2021 and held it in 9 quarters. The position peaked at $73.2M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Geode Capital Management reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Geode Capital Management sold 682,043 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $73.2M.
Geode Capital Management first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Geode Capital Management's Prometheus Biosciences, Inc. Common Stock position peaked at $73.2M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.